We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warner Chilcott, Mayne Seek $8 Million Settlement Over Generic Doryx Delay
Warner Chilcott, Mayne Seek $8 Million Settlement Over Generic Doryx Delay
Brand manufacturer Mayne Pharma and Warner Chilcott, U.S. marketer of Mayne’s acne drug Doryx, have moved to settle class action claims with third party purchasers that allege the two companies inappropriately delayed generic competition on the product.